Clinical Trial Update: HLAB-002 of ANS-6637 for Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial of ANS-6637 (HLAB-002) for alcohol use disorder was terminated, and results were posted in March 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• ANS-6637 (HLAB-002) (HLAB-002)

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcohol Use Disorder | Phase 2 | Status: TERMINATED | Results posted: 2022-03-10